Primary information |
---|
ID | antitb_1502 |
Peptide Name | Cyclomarin A |
Sequence | not available |
N-terminal Modification | NA |
C-terminal Modification | NA |
Chemical Modification | NA |
Linear/ Cyclic | Branched cyclic |
Length | 0 |
Chirality | D |
Nature | Cationic |
Source | Natural |
Origin | Derived from Streptomyces species |
Species | Mycobacterium tuberculosis |
Strain | Mycobacterium tuberculosis H37Rv |
Inhibition Concentartion | IC50= 0.3mg/ml |
In vitro/In vivo | in vitro |
Cell Line | NA |
Inhibition Concentartion | NA |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Response | |
Mechanism of Action | Change the clp1subunit of casinolytic protease by allosteric binding |
Target | NA |
Combination Therapy | NA |
Other Activities | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas |
Pubmed ID | 25681127 |
Year of Publication | 2015 |
3-D Structure | NA |